Severe Asthma pp 123-129 | Cite as

Non-pharmacologic Therapies for Severe Asthma

Chapter

Abstract

It is always important to provide a proper education and to build a partnership in the management of severe asthma. Clinical outcomes of severe asthma could be very dependent on non-pharmacological management such as education and partnership. Inhaler technique and adherence are the key factors of the successful management in severe asthma. Understanding that severe asthma is a chronic inflammatory airway disease would help maintain the regular medications and management. A written action plan is a very important strategy in self-management and should be provided to patients with severe asthma. Environmental factors such as inhalant allergens, smoking, air pollution, respiratory infections, and obesity can aggravate severe asthma and should be avoided appropriately. Immunization against respiratory infections is recommended. Comorbid conditions should be considered in the management of severe asthma. Future directions of non-pharmacological management in severe asthma are also discussed.

Keywords

Education Partnership Action plan 

References

  1. 1.
    Lee SM, Chang YS, Kim CW, Kim TB, Kim SH, Kwon YE, et al. Skills in handling turbuhaler, diskus, and pressurized metered-dose inhaler in korean asthmatic patients. Allergy Asthma Immunol Res. 2011;3(1):46–52.CrossRefPubMedGoogle Scholar
  2. 2.
    Jeong JW, Chang YS, Kim CW, Kim TB, Kim SH, Kwon YE, et al. Assessment of techniques for using inhalers in primary care physicians. Korean J Asthma Allergy Clin Immunol. 2011;31(2):116–23.Google Scholar
  3. 3.
    Kim SH, Kwak HJ, Kim TB, Chang YS, Jeong JW, Kim CW, et al. Inappropriate techniques used by internal medicine residents with three kinds of inhalers (a metered dose inhaler, Diskus, and Turbuhaler): changes after a single teaching session. J Asthma. 2009;46(9):944–50.CrossRefPubMedGoogle Scholar
  4. 4.
  5. 5.
  6. 6.
  7. 7.
    Fergeson JE, Patel SS, Lockey RF. Acute asthma, prognosis, and treatment. J Allergy Clin Immunol. 2017;139(2):438–47.CrossRefPubMedGoogle Scholar
  8. 8.
    Pawankar R, Holgate ST, Canonica GW, Lockey RF, Blaiss MS. WAO white book on allergy 2013 update. http://www.worldallergy.org/UserFiles/file/WhiteBook2-2013-v8.pdf.
  9. 9.
    Kim CY, Park HW, Ko SK, Chang SI, Moon HB, Kim YY, et al. The financial burden of asthma: a nationwide comprehensive survey conducted in the republic of Korea. Allergy Asthma Immunol Res. 2011;3(1):34–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Kim SH, Kim TW, Kwon JW, Kang HR, Lee YW, Kim TB, et al. Economic costs for adult asthmatics according to severity and control status in Korean tertiary hospitals. J Asthma. 2012;49(3):303–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Gotzsche PC, Johansen HK. House dust mite control measures for asthma. Cochrane Database Syst Rev. 2008;2:CD001187.Google Scholar
  12. 12.
    Fisseler-Eckhoff A, Bartsch H, Zinsky R, Schirren J. Environmental isocyanate-induced asthma: morphologic and pathogenetic aspects of an increasing occupational disease. Int J Environ Res Public Health. 2011;8(9):3672–87.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Park HW, Kim DI, Sohn SW, Park CH, Kim SS, Chang YS, et al. Outcomes in occupational asthma caused by reactive dye after long-term avoidance. Clin Exp Allergy. 2007;37(2):225–30.CrossRefPubMedGoogle Scholar
  14. 14.
    Oh SS, Kim KS. Occupational asthma in Korea. J Korean Med Sci. 2010;25(Suppl):S20–5.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Nagasaki T, Matsumoto H. Influences of smoking and aging on allergic airway inflammation in asthma. Allergol Int. 2013;62(2):171–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Lee SY, Chang YS, Cho SH. Allergic diseases and air pollution. Asia Pac Allergy. 2013;3(3):145–54.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Guan WJ, Zheng XY, Chung KF, Zhong NS. Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action. Lancet. 2016;388(10054):1939–51.CrossRefPubMedGoogle Scholar
  18. 18.
    Chauhan AJ, Johnston SL. Air pollution and infection in respiratory illness. Br Med Bull. 2003;68:95–112.CrossRefPubMedGoogle Scholar
  19. 19.
    Goings SA, Kulle TJ, Bascom R, Sauder LR, Green DJ, Hebel JR, et al. Effect of nitrogen dioxide exposure on susceptibility to influenza A virus infection in healthy adults. Am Rev Respir Dis. 1989;139(5):1075–81.CrossRefPubMedGoogle Scholar
  20. 20.
    Paulin L, Hansel N. Particulate air pollution and impaired lung function. F1000Res. 2016; 5:pii: F1000 Faculty Rev-201.Google Scholar
  21. 21.
    Watanabe M, Noma H, Kurai J, Sano H, Ueda Y, Mikami M, et al. Differences in the effects of Asian dust on pulmonary function between adult patients with asthma and those with asthma-chronic obstructive pulmonary disease overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;11:183–90.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Dougherty RH, Fahy JV. Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy. 2009;39(2):193–202.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
  24. 24.
    Park SM, Park JS, Park HS, Park CS. Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways. Allergy Asthma Immunol Res. 2013;5(5):258–76.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Ledford DK, Wenzel SE, Lockey RF. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma. J Allergy Clin Immunol Pract. 2014;2(6):653–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Kim YJ, Lim KH, Kim MY, Jo EJ, Lee SY, Lee SE, et al. Cross-reactivity to acetaminophen and celecoxib according to the type of nonsteroidal anti-inflammatory drug hypersensitivity. Allergy Asthma Immunol Res. 2014;6(2):156–62.CrossRefPubMedGoogle Scholar
  27. 27.
    Morales DR, Jackson C, Lipworth BJ, Donnan PT, Guthrie B. Adverse respiratory effect of acute β-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials. Chest. 2014;145(4):779–86.CrossRefPubMedGoogle Scholar
  28. 28.
    Porsbjerg C, Menzies-Gow A. Co-morbidities in severe asthma: clinical impact and management. Respirology. 2017;22(4):651–61.CrossRefPubMedGoogle Scholar
  29. 29.
    Dias-Junior SA, Reis M, de Carvalho-Pinto RM, Stelmach R, Halpern A, Cukier A. Effects of weight loss on asthma control in obese patients with severe asthma. Eur Respir J. 2014;43:1368–77.CrossRefPubMedGoogle Scholar
  30. 30.
    Dixon AE, Pratley RE, Forgione PM, Kaminsky DA, Whittaker-Leclair LA, Griffes LA, et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol. 2011;128:508–15.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Ulrik CS. Asthma and obesity. Curr Opin Pulm Med. 2016;22:69–73.CrossRefPubMedGoogle Scholar
  32. 32.
    Tay TR, Radhakrishna N, Hore-Lacy F, Smith C, Hoy R, Dabscheck E, et al. Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life. Respirology. 2016;21:1384–90.CrossRefPubMedGoogle Scholar
  33. 33.
    Teodorescu M, Broytman O, Curran-Everett D, Sorkness RL, Crisafi G, Bleecker ER, et al. Obstructive sleep apnea risk, asthma burden, and lower airway inflammation in adults in the Severe Asthma Research Program (SARP) II. J Allergy Clin Immunol Pract. 2015;3:566–75.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Julien JY, Martin JG, Ernst P, Olivenstein R, Hamid Q, Lemière C, et al. Prevalence of obstructive sleep apnea–hypopnea in severe versus moderate asthma. J Allergy Clin Immunol. 2009;124:371–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Serrano-Pariente J, Plaza V, Soriano JB, Mayos M, López-Viña A, Picado C, Vigil L, CPASMA Trial Group. Asthma outcomes improve with continuous positive airway pressure for obstructive sleep apnea. Allergy. 2017;72:802–12. doi: 10.1111/all.13070.CrossRefPubMedGoogle Scholar
  36. 36.
    Busk M, Busk N, Puntenney P, Hutchins J, Yu Z, Gunst SJ, et al. Use of continuous positive airway pressure reduces airway reactivity in adults with asthma. Eur Respir J. 2013;41:317–22.CrossRefPubMedGoogle Scholar
  37. 37.
    Tay TR, Radhakrishna N, Hore-Lacy F, Smith C, Hoy R, Dabscheck E, et al. Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life. Respirology. 2016;21:1384–90.CrossRefPubMedGoogle Scholar
  38. 38.
    Low K, Lau KK, Holmes P, Crossett M, Vallance N, Phyland D, et al. Abnormal vocal cord function in difficult-to-treat asthma. Am J Respir Crit Care Med. 2011;184:50–6.CrossRefPubMedGoogle Scholar
  39. 39.
    von Bülow A, Kriegbaum M, Backer V, Porsbjerg C. The prevalence of severe asthma and low asthma control among Danish adults. J Allergy Clin Immunol Pract. 2014;2:759–67.CrossRefGoogle Scholar
  40. 40.
    Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178:218–24.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Luyster FS, Strollo PJ Jr, Holguin F, Castro M, Dunican EM, Fahy J, et al. Association between insomnia and asthma burden in the Severe Asthma Research Program (SARP) III. Chest. 2016;15:1242–50.CrossRefGoogle Scholar
  42. 42.
    Kim MY, Lee SY, Jo EJ, Lee SE, Kang MG, Song WJ, et al. Feasibility of a smartphone application based action plan and monitoring in asthma. Asia Pac Allergy. 2016;6(3):174–80.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Kim BY, Lee J. Smart devices for older adults managing chronic disease: a scoping review. JMIR Mhealth Uhealth. 2017;5(5):e69.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Chan YY, Wang P, Rogers L, Tignor N, Zweig M, Hershman SG, et al. The Asthma Mobile Health Study, a large-scale clinical observational study using ResearchKit. Nat Biotechnol. 2017;35(4):354–62.CrossRefPubMedGoogle Scholar
  45. 45.
  46. 46.
  47. 47.
  48. 48.
    Yun HS, Rah WJ, Choi YJ, Kim JH, Oh JW, Kim HH, et al. The development of patient-tailored asthma prediction model for the alarm system. Allergy Asthma Respir Dis. 2016;4(5):328–39.CrossRefGoogle Scholar
  49. 49.
  50. 50.

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  1. 1.Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Bundang HospitalSeoul National University College of MedicineSeongnamSouth Korea

Personalised recommendations